Article
SF3B4 Drives Alternative 5′ Splice Site Selection of HOXA11-AS to Promote Metabolic Reprogramming and Reduced Cisplatin Sensitivity in ESCC
2026-08-12
Abstract excerpt
<title>Abstract</title> <p>Reduced cisplatin sensitivity limits treatment responses in esophageal squamous cell carcinoma (ESCC), yet the isoform-level RNA-processing mechanisms that connect metabolic adaptation to treatment response remain poorly defined. Here, integrative analyses of public datasets and clinical cohorts identified splicing factor 3b subunit 4 (SF3B4) as an ESCC-upregulated splicing regulator an...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 21517aae-a294-503e-bcbf-e4354bbc6e71
- DOI
- 10.21203/rs.3.rs-10663843/v1
